Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

SHE:301033 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	330.55	272.26	227.54	195.02	153.79	123.51
Other Revenue	6.18	6.18	3.33	0.24	-	-
Revenue	336.73	278.44	230.87	195.25	153.79	123.51
Revenue Growth (YoY)	21.99%	20.61%	18.24%	26.96%	24.51%	9.07%
Cost of Revenue	63.73	57.63	41.58	31.26	27.29	20.82
Gross Profit	273	220.81	189.29	163.99	126.5	102.69
Selling, General & Admin	129.13	114.04	116.17	105.57	73	59.63
Research & Development	36.22	27.09	26.78	30.61	25.88	16.28
Other Operating Expenses	2.86	0.62	2.1	2.04	0.66	1.12
Operating Expenses	168.21	141.84	145.09	138.25	99.49	77.07
Operating Income	104.78	78.97	44.2	25.74	27.01	25.62
Interest Expense	-0.03	-0.9	-2.21	-1.78	-0.49	-
Interest & Investment Income	4.78	5.48	5.45	9.78	6.49	5.04
Currency Exchange Gain (Loss)	0.44	0.44	-0.01	1.04	-0.47	-0.23
Other Non Operating Income (Expenses)	0.24	-0.26	-0.2	-0.13	-0.14	-0.13
EBT Excluding Unusual Items	110.2	83.72	47.24	34.65	32.4	30.31
Gain (Loss) on Sale of Investments	0.09	0.15	0.13	-0.81	0.98	0.4
Gain (Loss) on Sale of Assets	-2.07	0	-	0.17	0.01	0.08
Asset Writedown	-0.61	-0.48	-0.22	-1.29	-0.07	-0.65
Other Unusual Items	10.65	9.77	0.87	7.25	18.28	12.87
Pretax Income	118.25	93.16	48.02	39.96	51.6	43
Income Tax Expense	16.34	14.3	7.14	4.23	6.92	6.15
Earnings From Continuing Operations	101.91	78.85	40.88	35.73	44.68	36.86
Minority Interest in Earnings	-	-	-	0.16	0.03	0.11
Net Income	101.91	78.85	40.88	35.89	44.71	36.97
Net Income to Common	101.91	78.85	40.88	35.89	44.71	36.97
Net Income Growth	49.30%	92.90%	13.89%	-19.73%	20.95%	33.55%
Shares Outstanding (Basic)	66	66	66	66	57	49
Shares Outstanding (Diluted)	66	66	66	66	57	49
Shares Change (YoY)	1.32%	-0.33%	-0.80%	17.43%	14.83%	-0.28%
EPS (Basic)	1.55	1.20	0.62	0.54	0.79	0.75
EPS (Diluted)	1.54	1.20	0.62	0.54	0.79	0.75
EPS Growth	47.36%	93.55%	14.82%	-31.65%	5.33%	33.93%
Free Cash Flow	111.32	83.22	67.6	-87.65	-86.2	-27.74
Free Cash Flow Per Share	1.68	1.27	1.02	-1.32	-1.52	-0.56
Dividend Per Share	0.600	0.600	0.400	0.200	0.100	-
Dividend Growth	50.00%	50.00%	100.00%	100.00%	-	-
Gross Margin	81.07%	79.30%	81.99%	83.99%	82.25%	83.14%
Operating Margin	31.12%	28.36%	19.15%	13.18%	17.56%	20.74%
Profit Margin	30.26%	28.32%	17.71%	18.38%	29.08%	29.93%
Free Cash Flow Margin	33.06%	29.89%	29.28%	-44.89%	-56.05%	-22.46%
EBITDA	131.15	104.28	68.11	38.99	33.18	30.66
EBITDA Margin	38.95%	37.45%	29.50%	19.97%	21.57%	24.82%
D&A For EBITDA	26.37	25.31	23.91	13.25	6.17	5.04
EBIT	104.78	78.97	44.2	25.74	27.01	25.62
EBIT Margin	31.12%	28.36%	19.15%	13.18%	17.56%	20.74%
Effective Tax Rate	13.82%	15.35%	14.88%	10.58%	13.41%	14.29%
Revenue as Reported	336.73	278.44	230.87	195.25	153.79	123.51
Advertising Expenses	-	19.07	32.56	43.12	23.01	19.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.